CIMB flags broad corporate underperformance, stablecoin regulation advances, Musk reaffirms Tesla leadership, and Alps Global targets neurological disease treatment.

🇲🇾 Malaysia

• CIMB reports most Q1 results fell below expectations
  
• AEON Credit was a rare outperformer
  
• Wage gap narrows thanks to minimum wage policy reforms
  

🌍 International

• Singaporean faces US charges for leading crypto theft of US$263M
  
• Stablecoin bill clears US Senate hurdle
  
• Elon Musk says he’ll stay on as Tesla CEO for five more years
  
• Honda cuts EV investment; cites US tariffs and weak demand
  
• Apple’s smartphone exports to US hit 13-year low
  

🧬 Alps

• Alps begins new preclinical biotech research
  
• Focused on stem cell therapy for neurological conditions
  
• Part of broader regenerative medicine strategy

For more in-depth coverage, subscribe at agn.alps-holdings.com and stay updated with AGN.